Trial site
Arrow Clinical Trials
- 17running trials
- 5closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease10 trials
- Obstructive sleep apnoea3 trials
- High blood pressure2 trials
- Mild cognitive impairment2 trials
- Obesity2 trials
- Osteoarthritis2 trials
- Parkinson disease2 trials
- Type 2 diabetes2 trials
- Heart failure1 trial
- Multiple sclerosis1 trial
- Schizophrenia1 trial
- Phase
- Phase 312 trials
- Phase 25 trials
- Phase 2/32 trials
- Status
- Recruiting10 trials
- Active, not recruiting4 trials
- Completed4 trials
- Enrolling by invitation2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 trials
- Apnimed2 trials
- Cassava Sciences, Inc.2 trials
- Cognito Therapeutics, Inc.2 trials
- Eli Lilly and Company2 trials
- and 11 more
Running trials
Not yet recruiting
Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
Recruiting
Recruiting
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Enrolling by invitation
Enrolling by invitation
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease6 recruiting
- Obesity2 recruiting
- Parkinson disease2 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Mild cognitive impairment1 recruiting
- Obstructive sleep apnoea1 recruiting
- Osteoarthritis1 recruiting
- Schizophrenia1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026